Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M78,374Revenue $M23,113Net Margin (%)13.3Z-Score4.6
Enterprise Value $M79,183EPS $4.3Operating Margin %15.7F-Score4
P/E(ttm))28.1Cash Flow Per Share $5.4Pre-tax Margin (%)16.7Higher ROA y-yN
Price/Book4.410-y EBITDA Growth Rate %12.7Quick Ratio1.2Cash flow > EarningsY
Price/Sales3.75-y EBITDA Growth Rate %0.4Current Ratio1.6Lower Leverage y-yN
Price/Cash Flow9.1y-y EBITDA Growth Rate %-34.0ROA % (ttm)7.7Higher Current Ratio y-yN
Dividend Yield %2.8Insider Buy (3m)0ROE % (ttm)15.2Less Shares Outstanding y-yY
Payout Ratio %78.0Shares Outstanding M1,113ROI % (ttm)23.7Gross Margin Increase y-yN

Gurus Latest Trades with LLY

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LLYJohn Hussman 2014-09-30 Add1.67%$60.35 - $66.59
($63.3)
$ 70.3911%Add 6000%305,000
LLYKen Fisher 2014-09-30 Add0.02%$60.35 - $66.59
($63.3)
$ 70.3911%Add 2742.47%119,810
LLYJoel Greenblatt 2014-09-30 Reduce$60.35 - $66.59
($63.3)
$ 70.3911%Reduce -27.37%5,628
LLYDodge & Cox 2014-09-30 Add$60.35 - $66.59
($63.3)
$ 70.3911%Add 20.38%42,464
LLYCharles Brandes 2014-09-30 Reduce-0.29%$60.35 - $66.59
($63.3)
$ 70.3911%Reduce -14.27%2,303,062
LLYHOTCHKIS & WILEY 2014-09-30 Reduce-0.12%$60.35 - $66.59
($63.3)
$ 70.3911%Reduce -10.92%4,321,666
LLYDavid Dreman 2014-09-30 Reduce-0.02%$60.35 - $66.59
($63.3)
$ 70.3911%Reduce -84.4%900
LLYGeorge Soros 2014-09-30 Sold Out -0.02%$60.35 - $66.59
($63.3)
$ 70.3911%Sold Out0
LLYHOTCHKIS & WILEY 2014-06-30 Add0.73%$58.21 - $63.1
($59.62)
$ 70.3918%Add 199.7%4,851,480
LLYGeorge Soros 2014-06-30 Buy 0.02%$58.21 - $63.1
($59.62)
$ 70.3918%New holding, 50441 sh.50,441
LLYVanguard Health Care Fund 2014-06-30 Reduce-0.15%$58.21 - $63.1
($59.62)
$ 70.3918%Reduce -3.98%21,982,700
LLYRay Dalio 2014-06-30 Sold Out -0.02%$58.21 - $63.1
($59.62)
$ 70.3918%Sold Out0
LLYJohn Hussman 2014-06-30 Reduce-0.02%$58.21 - $63.1
($59.62)
$ 70.3918%Reduce -50%5,000
LLYPRIMECAP Management 2014-03-31 Add0.37%$50.73 - $59.85
($55.61)
$ 70.3927%Add 10.83%57,129,708
LLYHOTCHKIS & WILEY 2014-03-31 Buy 0.35%$50.73 - $59.85
($55.61)
$ 70.3927%New holding, 1618802 sh.1,618,802
LLYJoel Greenblatt 2014-03-31 Reduce-0.16%$50.73 - $59.85
($55.61)
$ 70.3927%Reduce -93.61%9,016
LLYRay Dalio 2014-03-31 Reduce-0.01%$50.73 - $59.85
($55.61)
$ 70.3927%Reduce -34.83%31,439
LLYVanguard Health Care Fund 2013-12-31 Add0.67%$47.65 - $51.34
($50.05)
$ 70.3941%Add 22.98%22,895,000
LLYCharles Brandes 2013-12-31 Add0.19%$47.65 - $51.34
($50.05)
$ 70.3941%Add 12.57%2,711,949
LLYJoel Greenblatt 2013-12-31 Add0.11%$47.65 - $51.34
($50.05)
$ 70.3941%Add 201.79%141,121
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LLY is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
LLY John Hussman 2014-09-30305,0000.031.7+6000%
LLY Ken Fisher 2014-09-30119,8100.010.02+2742.47%
LLY Dodge & Cox 2014-09-3042,46400+20.38%
LLY PRIMECAP Management 2014-09-3057,100,5455.134
LLY Vanguard Health Care Fund 2014-09-3021,982,7001.973.6
LLY Richard Pzena 2014-09-30430,1750.040.15-0.27%
LLY Mario Gabelli 2014-09-30114,6000.010.04-4.5%
LLY HOTCHKIS & WILEY 2014-09-304,321,6660.391-10.92%
LLY Charles Brandes 2014-09-302,303,0620.212-14.27%
LLY Joel Greenblatt 2014-09-305,62800-27.37%
LLY David Dreman 2014-09-3090000-84.4%
LLY George Soros 2014-09-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


LLY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LILLY ENDOWMENT INC10% Owner 2014-12-04Sell190,000$71.92-2.45view
LILLY ENDOWMENT INC10% Owner 2014-12-02Sell180,000$70.140.03view
LILLY ENDOWMENT INC10% Owner 2014-11-13Sell200,000$67.733.59view
LILLY ELI & CO 2014-11-12Buy164,963$13.5419.7view
Zakrowski Donald AChief Accounting Officer 2014-11-11Sell750$68.492.44view
LILLY ENDOWMENT INC10% Owner 2014-11-05Sell180,000$674.72view
Walsh Fionnuala MSVP, Global Quality 2014-11-04Sell15,000$674.72view
Conterno Enrique ASr. VP & Pres., Lilly Diabetes 2014-11-03Sell5,000$66.036.25view
Walsh Fionnuala MSVP, Global Quality 2014-10-31Sell7,376$66.585.38view
LILLY ENDOWMENT INC10% Owner 2014-10-31Sell190,000$66.45.66view

Press Releases about LLY :

    Quarterly/Annual Reports about LLY:

    News about LLY:

    Articles On GuruFocus.com
    Sarah Ketterer Dives in when Others Pull Out Nov 14 2014 
    Weekly 52-Week Highs Highlight: LLY, BG, NVS, HRL Sep 07 2014 
    Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt Figures Aug 28 2014 
    Eli Lilly is on the Right Track Jun 25 2014 
    John Paulson's Stocks Trading for Less Than He Paid for Them Jun 02 2014 
    Johnson & Johnson (JNJ) Dividend Stock Analysis May 29 2014 
    Can Pfizer Make Up Its Loss? May 09 2014 
    Will Pfizer’s Q1 2014 Earnings Beat the Street on May 5, 2014? May 05 2014 
    Vanguard Health Care Fund's Top Quarterly Holdings Apr 30 2014 
    These Three Pharmaceutical Companies Shake The Market With Their Deal Apr 27 2014 

    More From Other Websites
    Eli Lilly to sell heartworm line for Novartis deal approval Dec 22 2014
    Eli Lilly to sell heartworm line for Novartis deal approval Dec 22 2014
    FTC Puts Conditions on Lilly's Deal to Buy Novartis Unit Dec 22 2014
    Lilly must divest Sentinel products after FTC nod on Novartis deal Dec 22 2014
    Lilly must divest Sentinel products after FTC nod on Novartis deal Dec 22 2014
    Lilly to divest some Sentinel products to win approval on Novartis Dec 22 2014
    Lilly Announces Diabetes Research Partnership with University of Surrey Dec 22 2014
    Lilly Announces Diabetes Research Partnership with University of Surrey Dec 22 2014
    Lilly Announces Diabetes Research Partnership with University of Surrey Dec 22 2014
    Beta-Amyloid: The Emperor Really Does Have No Clothes Dec 20 2014
    Roche Drugs For Alzheimer's, Breast Cancer Disappoint Dec 19 2014
    LILLY ELI & CO Files SEC form 8-K, Change in Directors or Principal Officers Dec 19 2014
    Eli Lilly reaches insulin development deal with Adocia Dec 19 2014
    Eli Lilly reaches insulin development deal with Adocia Dec 19 2014
    Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone... Dec 19 2014
    Eli Lilly and Adocia agree to develop ultra-rapid insulin Dec 19 2014
    Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone... Dec 19 2014
    Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone... Dec 19 2014
    Lilly Sets Dates and Conference Calls for 2015 Financial Guidance and Fourth-Quarter 2014 Financial... Dec 17 2014
    Lilly Sets Dates and Conference Calls for 2015 Financial Guidance and Fourth-Quarter 2014 Financial... Dec 17 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK